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1 Introduction 
 
A disturbance in the blood vessels supplying blood to the brain can cause rapidly 
developing loss of brain functions which is called a stroke. This can be due to ischemia 
(lack of blood supply) caused by thrombosis or embolism or due to a hemorrhage. By 
the definition of WHO, stroke has to persist beyond 24 hours or to be interrupted by 
death within 24 hours. When stroke-like symptoms last under 24 hours it is called TIA 
(transient ischemic attac). Stroke is the most common cause of death in USA and 
Europe (1) after heart infarct and cancer and additionally the most common cause of 
invalidity in the general adult population. Worldwide it is the second common cause of 
death. (2)  The leading causes of death worldwide in 1990 were ischemic heart disease 
(6.3 million deaths), cerebrovascular accidents (4.4 million deaths), lower respiratory 
infections (4.3 million), diarrhoeal diseases (2.9 million), perinatal disorders (2.4 
million), chronic obstructive pulmonary disease (2.2 million), tuberculosis (2.0 million), 
measles (1.1 million), road-traffic accidents (1.0 million), and lung cancer (0.9 million). 
(2) Considerable amount of strokes occurs in population under 50 years old who are at 
the best age and still involved in the working life. (3) Thus strokes lead to early death, 
disabilities, invalidity and decreased employability. 
 
 The risk factors and etiology of strokes that occur in the young population differ 
significantly from strokes that take place among the elderly people. (4) The stroke rate 
in Finland has been calculated to be 270-304 per 100,000 per year between 1974 and 
1992. During past decades the incidense of stroke in Scandinavia and in western 
countries in general has decreased and it is espected to decrease also in the future. A 
Swedish  population-based epidemiological survey among young adults aged 18 to 44 
years in Northern Sweden observed in 1997 that the average annual incidence rate for 
ischemic stroke was 11.3/100 000 per year. (5)  Furthermore, in Norway the average 
annual incidence among people aged 15 to 49 years with first-ever cerebral infarction in 
1988-1997 was 11.4/100 000 per year. (6) Among the 1008 consecutive ischemic stroke 
patients aged 15 to 49 admitted to Helsinki University Central Hospital in 1994 to 2007, 
estimated annual occurrence of ischemic stroke was 10.8/100 000 (range 8.4 to 13.0), 
increasing exponentially with aging. (4) Treatment of stroke patients is most expensive 
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compared to other arteriolar illnesses. Thus it is important to recognize the risk factors 
to be able to do aggressive primary and secondary prevention.  
 
However, overt symptomatic strokes are just the top of an iceberg. Namely, silent brain 
infarcts and white matter changes called as leukoaraiosis are common findings among 
stroke patients and patients without other findings in brain imaging. Recently, these 
neuroimaging findings have been observed in younger stroke patients, as well. (4) In 
this MD-thesis project, current literature regarding leukoaraiosis and silent brain infarcts 
are reviewed and features of these changes in young patients with first-ever ischemic 
stroke are elucidated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3
 
 
2 Literature review 
 
2.1 Silent brain infarcts (SBI) 
 
Silent or subclinical strokes differ from symptomatic brain infarcts in lack of  stroke-
like symptoms. Thus patients with subclinical stroke do not notice any symptoms that 
relate to stroke. Prevalence and incidence of silent brain infarcts increase steeply with 
age and their frequency in older patient groups is approximately 20 %. (7) Silent brain 
infarcts are associated with an increased risk of stroke and the presence of silent brain 
infarcts increases the risk of a new silent infarct 3-fold. Silent infarcts have also value in 
predicting subsequent risk of vascular dementia. The prevalence of silent brain infarcts 
is five times greater than prevalence of the symptomatic strokes and underlying etiology 
is considered partly different. (7) In young adults, the implications and prognostic value 
of silent brain infarcts and leukoaraiosis are, however, not yet clarified and may not be 
fully similar as in elderly populations. 
 
Incidence of silent brain infarcts particularly in a population under fifty years old has 
not been studied earlier but it is estimated to be lower than in elder population. In 
previous community-based and population-based studies involving mostly elderly 
patients, the reported prevalence on silent brain infarcts on MRI have ranged between 8 
to 28%, depending mainly on age. (7)  In South-Korean study the prevalence of SBIs in 
those aged 20 to 39 was 0% and 1.7% in those aged 40 to 49. (8)  In Framingham 
Offspring Study the prevalence of SBIs among those aged 30 to 49 was less than 8%. 
The prevalence of SBIs in older Japanese patients (mean age 69) with first-ever 
ischemic stroke was as high as 57%, (9) which correlates well with the fact that the 
frequency of SBIs increases steeply along aging. However, small-vessel disease is very 
common in Japanese population and it is known to associate strongly with SBIs.   In the 
Rotterdam Scan Study the researchers discovered that subclinical brain infarcts and 
white matter changes in brain are independent risk factors for symptomatic stroke in 
general adult population and the result can not be explained by the risk factors of 
symptomatic stroke. (10) 
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Risk factors and etiology of silent brain infarcts is incompletely understood. The 
cardiovascular risk factors for silent brain infarcts such as high age, the presence of 
diabetes mellitus, increasing intima-media thickness and metabolic disorder are 
estimated to be the same as for symptomatic stroke. (11) 
 
Risk factor References of studies finding association 
Age 10-17 
Sex (female) 10, 15 
Family history of stroke 16 
Cardiovascular disease 15, 17 
Hypertension 10, 14-16 
Diabetes 14 
Carotid stenosis 15 
Intima-media thickness 11 
Atrial fibrillation 17 
Smoking 16 
Alcohol 18 
Hyperhomocysteinaemia 14, 19 
Fibrinogen 20 
Creatinine 15, 17, 21 
Cystatin C 21 
Migraine 13 
Retinal microvascular abnormalities 22 
Prevalent silent brain infarct 11 
Severe white-matter lesions 14, 17  
Metabolic syndrome 23 
Table 1. :Risk factors for MRI-defined silent brain infarcts; adapted from 
Vermeer et al. (7) This  table  takes  into  account  only  studies  that  find  a  clear  
association. 
 
Silent cerebral infarctions differ from symptomatic strokes also in size and location. 
Subclinical infarcts are usually small, deep and often situated in the basal ganglia. In the 
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Rotterdam Scan Study researchers detected silent lacunar infarcts in the basal ganglia in 
80% of the patients with silent infarcts. Furthermore, 33% of symptomatic strokes were 
situates cortically, whereas only 5% of the patients with silent infarcts had them situated 
in the cortex. (10) The location of silent cerebral infarctions was also noticed to be 
considerably different than that for the symptomatic infarction in the TOAST study. 
(24) They found out that there was more asymptomatic infarcts situated in the occipital 
lobe and basal ganglia and less clinically silent lesions in frontal, temporal and parietal 
lobes, internal capsule and corona radiata. (24) 
 
Silent infarcts are also frequently smaller than symptomatic strokes in all studies. In the 
Rotterdam  Scan  Study,  over  94%  of  the  silent  infarcts  were  lacunar.  Furthermore,  
symptomatic lacunar infarcts were larger than the asymptomatic ones. (25)  
 
 
 
Figure 1. T1-weighted MRI showing silent cortical infarct in the left temporo–occipital 
lobe (A), and a silent lacunar infarct in the right thalamus (B). (7) 
 
The term “lacunar infarct” refers to a radiological definition and does not necessarily 
correlate with underlying stroke etiology. (26,27) Lacunar infarcts are small deep 
infarcts with a diameter of 2-20mm. A quarter of all ischemic strokes are lacunar type. 
This leads us back to the pathogenesis of silent brain infarcts because lacunar infarcts 
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are caused mainly by small-vessel disease occluding a small perforating artery 
supplying the subcortical ares of the brain. A Japanese study discovered that silent 
subcortical infarcts are frequently lacunar and based on that they hypothesized that the 
pathogenesis of silent subcortical ischemic brain lesions is common to that of lacunar 
infarction meaning small-vessel vasculopathy. (9) 
 
Autopsy studies have revealed two types of underlying small-vessel pathologies. 
Microatheromatosis is associated with single or a few larger lacunar infarcts without 
leukoaraiosis and it is situated usually at the origins or proximal portions of the larger 
(200-800 µm in diameter) perforating arteries. Lipohyalinosis, which appears as an 
eosinophilic deposit in the connective tissue of the vessel wall, presents  as  a  diffuse  
arteriopathy of the smaller perforating arteries and is mainly associated with small, 
multiple and asymptomatic brain infarcts. It is also closely associated with endothelial 
dysfunction thus these lesions are postulated to occur secondary to damaged 
cerebrovascular autoregulation. Furthermore, periventricular leukoaraiosis is caused by 
lipohyalinosis of white matter perforating small arteries. Hypertension, age, diabetes 
and smoking are the main risk factors for lipohyalinosis, where as age, diabetes, 
hypercholesterolemia, smoking and myocardial infarction correlate better with cerebral 
large vessel disease (LVD). (25, 28) Diabetes mellitus is characterized by both 
microvascular and macrovascular pathology so it is obvious that it is associated with 
both large- as well as small vessel disease. 
 
In contrast to lacunar ischemic stroke, which is due to an intrinsic cerebral small 
arteriolar abnormality, cortical ischemic stroke is commonly due to embolism from the 
heart or large arteries. Nevertheless intracranial large artery atheromatous stenoses and 
other common causes of large artery infarction such as emboli appear to cause more 
than 10-15% of lacunar strokes. (29) The etiology behind lacunar strokes and large 
cortical stroke seems to be different. After lacunar ischemic stroke, a recurrence is more 
likely to be lacunar then cortical stroke. As mentioned above, silent lacunar infarcts 
increase the risk of stroke but at same time they increase the risk of new silent infarct by 
three fold. Furthermore, white matter lesions, that are also called leukoaraiosis, appear 
to be more closely associated with lacunar ischemic stroke than with cortical stroke.  
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2.2 Leukoaraiosis (LA) 
 
Cerebral white matter (WM) surrounds the subcortical gray matter (GM). It consists of 
axons and their myelin sheaths. White matter contains less water and more lipid than the 
GM. Cerebral blood in the white matter is only 25% (20ml/100g/min) from the blood 
flow per minute in the gray matter (80ml/100g/min). (30) The major function of the 
white matter is to provide neurons with structural support, maintain local conditions for 
neuronal function and to interconnect various regions of brain and transmit signals in-
between them. White matter of the brain is developed from the external marginal zone 
of neural tube and it forms approximately half of the brain weight and volume. (31)  
 
Cerebral white matter changes (WMC) are a common feature in the brain caused by 
aging but they are also found in a number of diseases of adulthood. Pathological white 
matter changes can be found in debated Binswanger’s disease, multiple sclerosis, acute 
demyelinating encephalomyelitis, posterior reversible leukoencephalopathy syndrome, 
cerebral anoxia, leukodystrophies, and mitochondrial encephalopaties, among others. 
Leukoaraiosis is also widely found in dementing illnesses, such as Alzheimer’s disease, 
vascular dementia, and cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy such as cerebral autosomal dominant arteriopathy 
(CADASIL). (32) 
 
White matter changes, i.e. leukoaraiosis, refers usually to nonspesific white matter 
changes. They can be detected primarily in the elderly and the lesions can not be 
attributed to a spesific disease. Leukoaraiosis comes from Greek words “leuko” 
meaning white and “araios” signifying rarefied or rarefaction. (33) These white matter 
changes in brain appear hypointense on CT (computer tomography) scans because of 
reduced X-ray attenuation and hyperintense on T2-weighted MRI (magnetic resonance 
imaging). (34) Size, shape and location varies. Leukoaraiosis can be focal, patchy or 
diffuse area in the white matter and it is situated periventricularly or deeper in the white 
matter. Mild degree of leukoaraiosis is considered to be a normal finding in the brain of 
elderly people. However, evidence has also accumulated showing that moderate-to-
severe white matter changes are correlated with motor and gait disturbances, depressive 
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symptoms, urinary disturbances and cognitive defecits. (35-37) Nevertheless, cognitive 
deficits are likely to be associated with lesions such as lacunar infarcts and coexisting 
degenerative diseases. (38) It is worth noticing that some individuals, regardless of the 
severity of leukoaraiosis, remain neurologically and neuropsychologically 
asymptomatic for prolonged periods while others develops major symptoms mentioned 
above.  
 
Leukoaraiosis increases mortality and risk of dementia. (39-42) The  presence  of   
leukoaraiosis increases the risk of small-vessel strokes, vascular mortality, intracerebral 
bleeding in patients on anticoagulation, bleeding in patients undergoing carotid artery 
surgery, predicts poorer clinical outcome in patients with infratentorial stroke, increases 
risk of dementia and transition to disability. (35) Leukoaraiosis also predicts infarct size 
growth in acute ischemic stroke. (43) Because of reasons mentioned above, 
leukoaraiosis is concidered as a marker of poor prognosis. 
   
Autopsy studies of the brain with leukoaraiosis have revealed that the lesions are 
strongly associated with arteriolar tortuosity, lacunar infarcts and incomplete infarctions 
as well as periventricular venous collagenosis, perivascular degeneration with widening 
of extracellular and perivascular spaces. Leukoaraiosis is also characterized with 
endothelial dysfunction, prothrombic changes like increased platellet activation and 
hypercoagulability and decline in cerebral perfusion. (44) Thus, it is thought to be a 
marker of compromised tissue perfusion because it is associated with a number of 
structural and functional vascular changes such as arteriosclerotic narrowing, 
elongation, tortuosity and impaired autoregulation. Resting cerebral blood flow is 
reduced up to 30% in brains with extensive leukoaraiosis. (43) Chronic ischemia and 
the increase in water content of the affected brain cause axonal loss and thus leads to 
inflammatory reaction, changes in myelin and compromised axonal transport. The 
structure of the white matter thins out in areas with leukoaraiosis because of apoptosis 
and gliosis. This leads to proliferation of glial cells and therefore gradual expansion of 
the lesions. (7) 
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Thus, leukoaraiosis is associated with factors that modulate tissue perfusion as well as 
tissue capacity for handling of ischemia. Leukoaraiosis is a composite product of 
multiple factors wich themselves seem to play a role in determining the tissue outcome 
after ischemia. (43)  The heritability of leukoaraiosis volume is detected to be 55% in 
general population and higher among women (78%) than among men (52%). (45) Thus, 
genetic variation is thought to play a major role in interindividual variation in 
leukoaraiosis volume. 
 
Leukoaraiotic lesion also appear to progress over time as well as the number of silent 
lacunar infarcts. Factors that seem to induce progression of leukoaraiosis are history of 
diabetes, high blood glucose and history of stroke. Progression is usually evidently 
situated  in  the  subcortical  white  matter  where  white  matter  changes  are  also  most  
common at baseline. The volume of leukoaraiosis at baseline and an increase of existing 
white matter changes correlate most significantly to the progression of leukoaraiosis. 
(46) 
 
Leukoaraiosis is a radiological finding and its pathogenesis or clinical significance is 
not well acknowledged. T2-weighted imaging is sensitive to liquid, gliosis and the 
effects of demyelination. FLAIR images are heavily T2-weigtened with cerebrospinal 
fluid suppression. This makes it possible to detect also leukoaraiotic lesions situated 
close  to  the  cerebrospinal  fluid  and  to  differentiate  Virchow-Robin  spaces  from  
leukoaraiosis. The decline in cerebral blood flow in areas with leukoaraiosis can be 
detected with imaging techniques such as average apparent diffusion coefficient 
(ADCav)  where  tissues  with  faster  diffusion  appear  bright  and  tissues  with  slower  
diffusion dark. Normally axons produce significant hindrance to water diffusion but 
leukoaraiosis causes axonal loss and furthermore leads to an increase in water content of 
the tissue which can be detected with these imaging techniques. DWI (diffusion-
weighted MRI) makes it possible to differentiate acute and chronic ischemic stroke 
lesions from leukoaraiosis. In DW images, tissues with faster diffusion appear dark and 
tissues with slower diffusion bright. (47) 
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To date, almost all stroke patients undergo brain imaging at least with computed 
tomography (CT) as they arrive at the hospital. In recent years an increasing amount of 
patients and especially young patients are being imaged also by MRI (magnetic 
resonance imaging), which makes the leukoaraiosis research easier because MRI is 
much more sensitive to leukoaraiotic changes than CT. Frequency of leukoaraiosis in 
older patient groups has ranged between 21% and 100% and in healthy subjects, it is 
found in 1-27% depending on the imaging method used and on the study population. 
Various rating scales also exist between studies. Some make a distinction between 
different regions, where as others use on overall estimate of leukoaraiosis.  
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3 Patients and methods 
 
This study was approved by the relevant authorities and performed at the Department of 
Neurology, Helsinki University Central Hospital. We included patients involved in the 
Helsinki Young Stroke Registry, (4) from 1994 to 2007, who had undergone an initial 
brain MR scan at 1.0 or 1.5 teslas. The patients were originally found by computer 
search of the hospital’s electronic database according to the following criteria: discharge 
diagnosis of an ischemic stroke, age 15–49 years at stroke onset, and patient living in 
the catchment area of the hospital. Only patients with first-ever ischemic stroke were 
included in the registry. In addition to those with false primary diagnosis, we excluded 
patients with transient ischemic attack (TIA), cerebral venous thrombosis, stroke due to 
direct head trauma or strangulation, ischemic lesion due to immediate complications 
originating from subarachnoidal hemorrhage, and any iatrogenic stroke as a 
consequence of angiographic imaging or major surgery. Of the 1,194 consecutive 
patients found by the computer search, 1,008 were included in the registry, and of these, 
671 patients were initially scanned with MRI. Of the MR-scanned patients, 669 had 
complete imaging data, being eligible for the present study. They represented well the 
entire cohort of 1,008 patients. 
 
We obtained demographic and risk factor data from the medical records. The definitions 
of risk factors were based on information available before the onset of the stroke, and on 
all poststroke diagnostic testing related to the current stroke. All patients underwent 
routinely a range of laboratory testing, which are described in detail elsewhere. (4) 
Family history of any stroke was defined as history of ischemic or hemorrhagic stroke, 
or TIA, in a first-degree relative. Dyslipidemia was defined as treated with lipid-
lowering medication or total cholesterol level ?5.0 mmol/L (193 mg/dL), low-density 
lipoprotein level ?3.0mmol/L (116 mg/dL), or high-density lipoprotein level 
<1.0mmol/L (39 mg/dL). Hypertension was defined as treated with antihypertensives, 
or a history or present diagnosis of hypertension according to the 2003 World Health 
Organization criteria as systolic blood pressure ?140 mm Hg and/or diastolic blood 
pressure ?90 mmHg. A patient was considered as current smoker if smoking regularly 
?1 cigarettes per day within the year before stroke. We defined obesity as body mass 
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index (BMI) ?30 kg/m2 or patient clearly stated as heavily obese if BMI data were not 
available. Cardiovascular disease was defined as any of coronary heart disease, heart 
failure, myocardial infarction, or peripheral arterial disease. Diabetes mellitus type 1 
and 2 were separately registered and defined as treated or presently diagnosed according 
to the 1999 World Health Organization criteria as fasting plasma glucose ?7.0 mmol/L 
(126 mg/dL). In Finland, children and young adults with newly diagnosed type 1 
diabetes are almost invariably diagnosed and treated in hospital, and the diagnosis is 
based on clinical characteristics, C-peptide measurements, and where necessary, 
glutamate decarboxylase antibody measurements. The type of diabetes is thus reliably 
distinguished based on information obtained from the medical records. Other registered 
risk factors were chronic or paroxysmal atrial fibrillation, and migraine, the latter 
defined according to the International Headache Society criteria. (48) 
 
We classified stroke subtypes according to the Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) criteria. (49) A pair of investigators assigned the stroke subtype to 
each patient, and in case of discrepancy, the patient records were reviewed by a senior 
investigator and the final categorization was based on a consensus agreement of all 
three. 
 
All brain imaging studies were originally interpreted by neuroradiologists. Analysis and 
rating of SBIs and leukoaraiosis were performed by study stroke neurologists and senior 
neuroradiologist (O.S.) blinded to clinical data. We defined SBI as focal hyperintensity 
on T2-weighted images, 3 mm in size or larger, and without a history of corresponding 
neurologic symptoms or signs. To distinguish infarcts from leukoaraiosis, infarcts had 
to have corresponding hypointensity on T1-weighted images. We measured the 
diameter of each SBI in millimeters using axial images and registered brain side, as well 
as calculated the number of SBIs for each patient. Localization of each SBI was 
classified as follows: cortical, cerebellum, brainstem (including pons), thalamus, lacune 
subcortical, and lacune basal ganglia. Leukoaraiosis was defined as hyperintense lesions 
in periventricular or subcortical regions, or in pons, on fluid-attenuated inversion 
recovery MRI sequences, and, in two patients, on T2-weighted sequences. We evaluated 
leukoaraiosis according to a previously validated visual rating scale developed in our 
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hospital. (50) The reliability of rating have been tested and found to be good 
(intraobserver agreement, weighted ?= 0.90–0.95; interobserver agreement, weighted ?= 
0.72– 0.84). (50) Periventricular hyperintensities (PVHs) around frontal and occipital 
horns, along the bodies of lateral ventricles, and in regions other than periventricular 
white matter were classified and scored based on shape and size of the lesions (table 1). 
Presence of pontine leukoaraiosis was additionally scored. Scores of these four 
components were added up for each patient, and the sum score was categorized into 
mild (1– 4), moderate (5– 8), or severe (9 –12). Presence of leukoaraiosis was thus 
defined as any score greater than zero. 
 
Chi-square and Fisher exact tests allowed comparisons of categorical variables between 
the groups. The Student t test was used for comparisons of means, and the Mann–
Whitney U test was used for ordinal variables. Historic risk factor information based on 
self-reporting (migraine, smoking, and family history of stroke) that was not mentioned 
in the medical records was considered as being not present. Otherwise, there were no 
missing values in risk factor variables. All statistical analyses used SPSS 15.0 for 
Microsoft Windows (SPSS Inc., Chicago, IL). Two-sided values of p <0.05 were 
considered significant. 
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From the left:  a. Small caps around the frontal horns of lateral ventricles. b. Large caps. c Extending 
caps. 
 
d. Thin lining along the bodies of the lateral ventricles. e.  Smooth halo. f.  Irregular halo 
 
g. Multiple small focal lesions h. Multiple large focal lesions i. Multiple focal confluent lesions 
 
j.  Diffusely confluent lesions irregular in shape k,l. Extensive WM changes 
 
Figure 2. Periventricular white matter changes (a-f) and white matter changes in 
regions other than the periventricular area (g-l) (FLAIR images) (31) 
  
15
 
 
Table 1. Characteristics of Patients with MRI-Defined Leukoaraiosis, Leukoaraiosis 
Score, and Features of Silent Infartcts in These Patients (N=50). 
Characteristics  
Periventricular hyperintensities (PVH) around frontal 
and occipital horns (score)  
 Absent (0) 1 (2) 
 Small cap (1)  24 (48) 
 Large cap (2) 17 (34) 
 Extending cap (3) 8 (16) 
PVH along the bodies of lateral ventricles (score)  
 Absent (0) 1 (2) 
 Thin lining (1) 38 (76) 
 Smooth halo (2) 7 (14) 
 Irregular halo (3) 4 (8) 
Hyperintensities in the regions other than 
periventricular white matter (score)  
 Absent (0) 9 (18) 
 Small focal lesions (1) 13 (26) 
 Large focal lesions (2) 9 (18) 
 Focal confluent lesions (3) 10 (20) 
 Diffusely confluent lesions (4) 8 (16) 
 Extensive white matter change (5) 1 (2) 
Pontine leukoaraiosis (score)  
 Absent (0) 43 (86) 
 Present (1) 7 (14) 
Leukoaraiosis score (0-12)  
 Mean 5.0 (±2.1) 
 Median 5 
 Range 2-10 
 Males, median score 5 
 Females, median score 4 
 Mild to moderate (1-6) 36 (72) 
 Severe (7-12) 14 (28) 
Silent brain infarcts  
 Present 17 (34) 
 Average size, mm 10 (±7) 
Silent brain infarct location  
 Cortical 2 (4) 
 Cerebellar 4 (8) 
 Brainstem 5 (10) 
 Thalamus 5 (10) 
 Lacune subcortical 5 (10) 
 Lacune basal ganglia 11 (22) 
Data are expressed as n (%) or mean (±SD). 
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4 Results 
 
Of the 669 patients included, 86 (13%) had one or more SBIs and 50 (7%) had 
leukoaraiosis. Among these, 17 (3%) had both findings. In total, 550 (82%) patients 
were free of SBIs and leukoaraiosis, serving as a control group. In the study population, 
SBIs began to appear at age 26 years and leukoaraiosis began to appear at age 35 years, 
whereas 
the proportion of patients free of SBIs and leukoaraiosis strikingly decreased with aging 
(figure 3). 
 
5 %5 % 4 %
8 %
10 % 8 %
6 %
11 %
14 %
100 % 100 %
90 % 92 % 89 %
82 %
73 %
0 %
20 %
40 %
60 %
80 %
100 %
Age-Group
Without SBIs and 
Leukoaraiosis
SBIs
Leukoaraiosis
SBIs and 
Leukoaraiosis
 
Figure 3. Proportions of Patients with MRI-defined Silent Brain Infarcts (SBI) or 
Leukoaraiosis as a Function of Age in the Patient Cohort (N=669). 
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We identified a total of 276 SBIs in our patients. The majority (n =46, 54%) had only a 
single lesion, 17 (20%) had two lesions, and 23 (27%) patients had three or more 
lesions. SBIs were located mostly in basal ganglia and subcortical regions, but silent 
lesions in cerebellum were rather frequent as well (figure 4). 
 
Cortical (29 mm)
8 %
Cerebellum (11 mm)
15 %
Brainstem (7 mm)
7 %
Thalamus (7 mm)
9 %
Lacune Subcortical 
(9 mm)
21 %
Lacune Basal 
Ganglia (8 mm)
39 %
 
Figure 4. Locations of MRI-Defined Silent Brain Infarcts and Average Size of Lesions 
in Each Location. 
 
The majority of patients had right-sided SBIs (n = 37, 43%), whereas 22 patients (26%) 
had left-sided lesions, and 27 patients (31%) had bilateral SBIs. The average SBI 
diameter was 9 mm, ranging from 3 to 83 mm, the latter in a 46-year-old man with an 
SBI in the right frontotemporal cortex. Most patients with leukoaraiosis had mild to 
moderate changes. Males had a slightly higher leukoaraiosis score (mean score 5.4 ± 2.0 
vs 4.7 ±2.2, p =0.217). SBIs were located mainly in basal ganglia in those 17 with 
concurrent leukoaraiosis and SBIs. PVHs around frontal and occipital horns most often  
appeared in the forms of a small or large cap. PVHs along the bodies of lateral 
ventricles were mostly characterized by thin lining. Hyperintensities in regions other 
than periventricular white matter varied the most from small focal lesions to extensive 
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white matter change, the latter in a patient with a long history of untreated grave 
hypertension and acute presentation of hypertensive encephalopathy and ischemic 
stroke (Table 1). Stroke risk factors and etiology of the first-ever overt stroke in the 
study population are shown in table 2. 
 
Table 2. Demographic Data, Risk Factors, and Subtypes of Clinically Overt Brain 
Infarcts in the Study Population and Patients with MRI-Defined Silent Brain Infarcts 
(SBI), and Leukoaraiosis Compared with Controls Free of These Findings. 
Variables Overall (N=669) 
Controls 
(n=550) 
 SBI Present 
(n=86) 
LA  
Present 
(n=50) 
SBIs and 
Leukoaraiosis 
(n=17) 
Age, years 39.9 (±8.0) 39.1 (±8.3) 43.1 (±6.0)** 45.4 (±4.0)** 46.4 (±3.4)** 
Males 389 (58) 317 (58) 56 (65) 25 (50) 9 (53) 
Family history of any stroke 88 (13) 72 (13) 10 (12) 9 (18) 3 (18) 
Dyslipidemia 372 (56) 293 (53) 57 (66)* 30 (60) 8 (47)  
Hypertension 247 (37) 181 (33) 47 (55)** 33 (66)** 14 (82)** 
Cigarette smoking 266 (40) 210 (38) 43 (50)* 23 (46) 10 (59) 
Obesity 62 (9) 40 (7) 14 (16)* 10 (20)* 2 (12) 
Cardiovascular disease 46 (7) 31 (6) 12 (14)* 7 (14)* 4 (24)*  
Diabetes mellitus, type 1 29 (4) 13 (2) 10 (12)** 10 (20)** 4 (24)*  
Diabetes mellitus, type 2 37 (6) 25 (5) 9 (11)* 3 (6) 0  
Atrial fibrillation 19 (3) 16 (3) 2 (2) 1 (2) 0 
Carotid stenosis >25% 37 (6) 24 (4) 8 (9) 9 (18)* 4 (24)* 
History of migraine 138 (21) 122 (22) 13 (15) 4 (8)* 1 (6)  
Etiology of the first-ever overt ischemic stroke (TOAST classification) 
Large-artery atherosclerosis 37 (6) 22 (4) 10 (12)* 8 (16)* 3 (18)* 
Cardioembolism 118 (18) 98 (18) 16 (19) 6 (12) 2 (12) 
Small-vessel disease 91 (14) 51 (9) 27 (31)** 22 (44)** 9 (53)** 
Other determined etiology 193 (29) 173 (32) 16 (19)* 7 (14)* 3 (18) 
Undetermined etiology 230 (34) 206 (38) 17 (20)* 7 (14)* 0 
Data are expressed as mean±SD or n (%).  
* P<0.005; **P<0.001 
TOAST, Trial of Org 10172 in Acute Stroke Treatment. 
 
As expected, patients with SBI, leukoaraiosis, or both were older compared with 
controls free of these findings. Hypertension, both types of diabetes, cardiovascular 
disease, obesity, smoking, and dyslipidemia were more frequent in patients with SBIs 
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compared with controls. In patients with leukoaraiosis, hypertension, obesity, type 1 
diabetes mellitus, and cardiovascular disease were more common.  
SBIs and leukoaraiosis clearly were more often present in patients with first-ever overt 
infarct associated with small-vessel disease or large-artery atherosclerosis, and less 
common in those with other determined or undetermined etiology. In patients with 
SBIs, the specific causes of stroke in the other determined category (TOAST 4) were as 
follows: primary angiitis of the central nervous system (PACNS) (n = 5), cervical artery 
dissection (4), hypertensive encephalopathy (2), factor V Leiden mutation (2), 
(CADASIL) (1), systemic lupus erythematosus (SLE) (1), and radiation vasculopathy 
(1). Accordingly, leukoaraiosis was found in those with PACNS (n =2), CADASIL (2), 
hypertensive encephalopathy (1), SLE (1), and radiation vasculopathy (1).  
(Females tended to have an increased risk for leukoaraiosis; otherwise, we observed no 
clear sex preference. Hypertension had only a trend-like association with both SBIs and 
leukoaraiosis alone. In addition to increasing age, smoking, hypertension, and in 
particular type 1 diabetes were independent predisposing factors in those with 
concurrent SBIs and leukoaraiosis.) 
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5 Discussion 
 
SBIs and leukoaraiosis were common findings among our young stroke patients. SBIs 
were seen already in early adulthood, whereas leukoaraiosis began to appear at early 
midlife. Apart from increasing age, juvenile-onset diabetes mellitus was the strongest 
risk factor for both SBIs and leukoaraiosis in this young patient population. 
 
In our young patients, the prevalence of SBIs and leukoaraiosis increased with aging 
and occurred in parallel with the exponentially increasing occurrence rate of first-ever 
overt ischemic stroke. (4) More than one-fourth among patients aged 45–49 years and 
nearly one-fifth among patients aged 40–44 years had SBIs, leukoaraiosis, or both 
(figure 1). In previous community-based and population-based studies involving mostly 
elderly persons, the reported prevalences of SBIs on MRI have ranged from 8% to 28% 
and have depended mainly on age. (7) Two studies have documented the prevalence of 
SBIs in detail in healthy middle-aged subjects: the prevalence among younger 
participants was 0% in those aged 20–39 years and 1.7% in those aged 40–49 years in a 
South Korean study, (8) and <8% among those aged 30–49 years in the Framingham 
Offspring Study. (51)The prevalence of MR-defined SBIs in older Japanese patients 
(mean age 69 years) with first-ever ischemic stroke was 57%. (9) This high percentage 
may well correlate with our observations of the steeply increasing frequency of SBIs 
with aging. However, Japanese are known to have a high frequency of small-vessel 
disease, which associates strongly with SBIs. 
 
Akin to previous studies, which have enrolled mostly elderly persons, (8, 10,13,15, 51-
53) most SBIs in our patients were located in subcortical deep white matter and basal 
ganglia, which thus reflect the probable underlying small-vessel pathology. However, 
we observed a considerably higher proportion of silent cerebellar infarcts (15%) in our 
young patients compared with that registered in the healthy elderly (1%–8%) (8, 10, 15, 
51, 52) or in patients with acute ischemic stroke scanned with CT (7%). (24) Migraine 
was suggested as an independent risk factor particularly for cerebellar silent ischemic 
lesions in the general population. (54) In contrast, we did not find such association in 
our young stroke patients. Thus we find it possible that the association between 
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migraine and young patients with SBIs in studies is due to the fact that migraine appears 
more often in young.  Compared with our series, participants in that study (54) were 
older, and only four were younger than 50 years, which prbably reflects that increasing 
age is the major predisposing factor for SBIs in migraineurs as well. Silent 
cardioembolism may in part explain the frequency of cerebellar SBIs in our patients, 
because those with identified cardioembolic source underlying the overt stroke were 
rather numerous. As observed, younger stroke patients tend to have more frequently 
overt posterior territory ischemia and cerebellar infarcts. (4) This observation, jointly 
with the frequency of cerebellar SBIs, might reflect the same—yet unclear—
pathophysiologic mechanisms. The observed side preference of SBIs likely reflects the 
fact that symptoms arising from lesions in the nondominant hemisphere are not well 
recognized even in the young. (4) 
 
Leukoaraiosis is increasingly apparent after age 50 years, and the prevalence is very 
high in elderly populations. (12, 14, 55, 56) In mostly older patients with TIA or stroke, 
leukoaraiosis was present in 44%. (57) A community-based Japanese study revealed a 
prevalence of a few percent in participants in their 40s. (14) In our study, the prevalence 
was 6% both in patients aged 35–39 years and in those aged 40–44 years but doubled in 
the age group of 45–49 years, which reflects that age is also the major determinant for 
leukoaraiosis. (58) We used a leukoaraiosis rating scale that takes into account the 
number, size, and shape of leukoaraiotic lesions. (31) According to our simple scoring 
system—considering all white matter areas and brainstem—our young patients had 
mostly mild to moderate leukoaraiotic changes, whereas males had 
slightly more severe lesions. The latter is opposite to the trend observed in the general 
population. (55) However, our relatively small number of patients with leukoaraiosis 
may not allow firm conclusions on this issue. 
 
Silent myocardial infarctions are frequently seen among patients with type 1 diabetes, 
(59) but to our knowledge, the strong associations between type 1 diabetes and early-
onset SBIs or leukoaraiosis have not been previously observed. Results on the 
association of type 2 diabetes with both SBIs and leukoaraiosis in elderly populations 
have been conflicting. (7, 14, 51, 52, 58, 60) This may be due to weak associations, 
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small sample sizes, or a combination of both. Interestingly, the well-established 
associations between hypertension and SBIs (7) and leukoaraiosis (60) were not that 
clear in our series, and were only seen in those with coexistent SBIs and leukoaraiosis, 
who also were older. Likely explanations for these observations are that in younger 
patients, hypertension may not have had enough time to cause advanced vessel 
pathology, whereas juvenile-onset diabetes and chronic hyperglycemia may have altered 
the endothelial function, leading to early atherosclerosis, possibly for years or decades 
before stroke. (61) 
  
Recently, there has been a growing attention on the association between metabolic 
syndrome, its components, and SBIs (23) as well as leukoaraiosis. (62) This association 
is also obvious in our series, because obesity was related with the presence of both SBIs 
and leukoaraiosis. Smoking was associated with SBIs only in two prior studies, (7) but 
its relation to pathogenesis of leukoaraiosis or small-vessel disease is even more 
controversial. (28, 58) Accordingly, in our young patients, smoking was associated with 
SBIs but not with leukoaraiosis. However, as with hypertension, smoking was clearly 
associated with coexistent SBIs and leukoaraiosis. 
 
Small-vessel disease is the most likely stroke subtypeassociated with the presence of 
both SBIs (7) and leukoaraiosis. (57) Given the overall high frequency of vascular risk 
factors in our patients, (4) those with non-small-vessel disease related stroke also may 
harbor risk factors predisposing to small-vessel pathology. This is obvious particularly 
in those with large-artery atherosclerosis. In addition, SBIs may well be related to 
conditions such as cervical artery dissection or PACNS per se, considering their 
pathophysiologic mechanisms and often slowly or gradually evolving pathogenesis. (63, 
64) Both SBIs and leukoaraiosis are characteristic even in younger patients with 
CADASIL. (65) 
 
Our study has several limitations. It covers a long time period and is subject to 
variability in MR technology. We may have misclassified a few SBIs because 
of incomplete patient history information or because some patients may not recall their 
stroke symptoms or correctly interpret all their previous symptoms. The Helsinki Young 
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Stroke Registry includes only patients younger than 50 years and with first-ever 
ischemic stroke, reducing this possibility. Approximately one-third of our patients in the 
registry were scanned only with CT and were excluded from the present study, which 
may have led to slight underestimation of small SBIs in the entire cohort of 1,008 
consecutive patients. However, including only MR-scanned patients was reasonable 
because sensitivity to detect and classify infarcts on MRI is clearly better than on CT. 
(7) Because of the study design, we may have underestimated the prevalence of some 
historic risk factors, such as smoking or family history of stroke. Numbers of patients 
particularly in the leukoaraiosis and combined SBI and leukoaraiosis groups were 
relatively small, (which should be taken into account when interpreting the results of the 
multivariate analyses.) Finally, because we included only stroke patients, the issue of 
whether the observed risk factor associations also are present in young people without 
any history of an overt stroke should be tested in large-scale studies. 
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6 Conclusions 
 
Based on previous community-based and population-based studies involving mostly 
elderly patients silent brain infarcts and white matter changes called as leukoaraiosis are 
common findings among stroke patients and patients without other findings in brain 
imaging. However they do not appear to be very uncommon findings among young 
adults either. Silent brain infarcts appear as focal hyperintensity in brain on T2-
weighted images without a history of corresponding neurologic symptoms or signs. To 
distinguish infarcts from leukoaraiosis, infarcts have corresponding hypointensity on 
T1-weighted images. Leukoaraiosis can be detected as hyperintense lesions in 
periventricular or subcortical regions, or in pons, on fluid-attenuated inversion recovery 
MRI sequences or respectively on T2-weighted sequences. 
  
The most widely accepted risk factors for silent brain infarcts are cardiovascular risk 
factors such as high age, the presence of diabetes mellitus, obesity and smoking. 
Furthermore, the most essential risk factors for leukoaraiosis are type 1 diabetes, 
obesity, female sex, and increasing age. Not to mention that small-vessel disease is the 
predominant cause of stroke in both groups. Silent brain infarcts are associated with an 
increased risk of stroke, a new silent brain infarct and vascular dementia. Furhermore, 
leukoaraiosis appear to be more closely associated with lacunar ischemic stroke than 
with cortical stroke. Leukoaraiosis alone is correlated with motor and gait disturbances, 
depressive symptoms, urinary disturbances, cognitive defecits, increased mortality, 
poorer clinical outcome of stroke, transition to disability and overall poor prognosis. 
Thus it is very important to find patients with silent brain infarcts and/or leukoaraiosis. 
This group of people, particularly young adults, would benefit from more frequent 
medical monitoring and aggressive prevention of stroke and dementia. Furthermore this 
kind of prevention theraphy requires prolonged monitoring which would benefit from 
persistent relationship between patient and nursing staff.          
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